About Us

Qubigen is an end-to-end AI software platform and drug design company with key differentiators in market: ​​​​

​

 

Patented, Secure Federated AI

Qubigen's technology is 14x faster and 187x more cost-effective, extracting insights from data without moving or directly accessing it.

 

​

Accelerated Drug Development

Our AI-generated drug candidates are optimized for both binding and tailored drug-like properties, accelerating the hit-to-lead stage. Revive your stalled projects with collaborative opportunities, and help cure tough diseases.

 

​

End-to-End Platform

Qubigen provides a unified software system with in-house curated ADMET database, internally controlled algorithms, and multidisciplinary team (data science, AI, chemistry), plus secure data portal for iterative AI drug generation.

 

​

Proven Success

We are supported by case studies, major institutional partnerships and access to med-chemistry wet labs for molecule design and preclinical testing.